The participants on oral medication had 4.22 times higher odds of having postpartum glucose intolerance (a0R=4.22, 95% CI=1.74-10.23, P=0.001), while those on a combination of oral medication and insulin exhibited 14.22 times higher odds (a0R=14.22, 95% CI= 1.81—111.39, P=0.012). The gene discussed is INS; the disease is Glucose intolerance.